Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pituitary Neoplasms × Capecitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 401 Colorectal Neoplasms 312 Rectal Neoplasms 232 Stomach Neoplasms 208 Pancreatic Neoplasms 137 Neoplasm Metastasis 123 Colonic Neoplasms 93 Neoplasms 86 Triple Negative Breast Neoplasms 64 Esophageal Neoplasms 57 Biliary Tract Neoplasms 37 Nasopharyngeal Carcinoma 35 Cholangiocarcinoma 31 Adenocarcinoma 31 Carcinoma, Hepatocellular 30 Gallbladder Neoplasms 29 Bile Duct Neoplasms 21 Carcinoma, Non-Small-Cell Lung 20 Adenocarcinoma Of Esophagus 20 Squamous Cell Carcinoma of Head and Neck 19 Locally Advanced Rectal Cancer 19 Brain Neoplasms 19 Gastrointestinal Neoplasms 18 Liver Neoplasms 17 Head and Neck Neoplasms 17 Parkinson Disease 4, Autosomal Dominant Lewy Body 16 Esophageal Squamous Cell Carcinoma 16 Colorectal Cancer Metastatic 15 Ovarian Neoplasms 14 Breast Neoplasms, Male 14

Interventions

pasireotide 7 Cabergoline 7 Surgical Procedures, Operative 4 Temozolomide 3 Propofol 3 Hydrocortisone 3 Dexmedetomidine 3 lanreotide 2 Sevoflurane 2 Saline Solution 2 Rosiglitazone 2 Radiotherapy 2 Radiosurgery 2 Proton Therapy 2 Octreotide 2 Human Growth Hormone 2 Dexamethasone 2 Desflurane 2 Aminolevulinic Acid 2 pegvisomant 1 parecoxib 1 lutetium Lu 177 dotatate 1 loxoprofen 1 farletuzumab 1 entinostat 1 corticorelin ovine 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Yoga 1 Visual Field Tests 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03930771 2022-08-09

TMZ-Cap

Weill Medical College of Cornell University

Phase 2 Terminated

1 enrolled 8 charts

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡